Organigram Holdings | OGI - Ebit

Stock Price
1.48
Daily Change
-0.02 -1.33%
Monthly
-28.50%
Yearly
-20.86%
Q2 Forecast
1.84

Organigram Holdings reported CAD-20.13M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Acasti Pharma USD -3.7M 1.13M Dec/2024
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Aurora Cannabis CAD -35.79M 8.96M Dec/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Cronos Group USD -1.45M 5.61M Mar/2026
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Ionis Pharmaceuticals USD -118M 97M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Moderna USD -1.39B 531M Mar/2026
Organigram Holdings CAD -20.13M 7.92M Dec/2025
Organon & Co USD -27M 415M Dec/2025
Revvity USD 82.77M 63.06M Mar/2026
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 16.77M 8.88M Dec/2025